Wang Y C, Huang Y H, Chang H, Yao W, Yan X E, Li K, Zhang Y P, Zheng W
Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.
Beijing Da Xue Xue Bao Yi Xue Ban. 2020 Nov 11;53(1):204-209. doi: 10.19723/j.issn.1671-167X.2021.01.031.
To distinguish the endoscopic and clinical features of ampullary polyps, to investigate the endoscopic cancer risk factors of ampullary polyps based on the compared differences of benign lesions and adenocarcinoma, and to assess the accuracy of forceps biopsy.
Authors retrospectively analyzed the data extracted from patients treated with endoscopic papillectomy (EP) from January 2009 to May 2019 in the Department of Gastroenterology, Peking University Third Hospital. Endoscopic pictures and pathology reports were reevaluated and analyzed. Differences between benign and cancer groups were conducted.
In the study, 42 cases were involved, 35 to 83 years old, containing 83.3% older than 50 years old patients. The histological types were as follows, 2 for inflammatory polyps (4.8%), 1 for neuroendocrine tumor (2.4%), 1 for hyperplastic polyp (2.4%), 5 for grade Ⅰ adenoma (11.9%), 10 for grade Ⅱ adenoma (23.8%), 4 for grade Ⅲ adenoma (9.5%) and 19 for adenocarcinoma (45.2%), and 90.5% were adenoma or adenocarcinoma. The average age of benign group (inflammatory polyps and adenomas) was (56.7±9.2), which was significantly younger than that of adenocarcinoma group [(66.0±9.8), =0.004]. Tumor diameter in adenocarcinoma group[(2.3±0.8) cm] was significantly larger than that in benign group[(1.6±0.6) cm, =0.002]. Benign lesions only showed Yamada type Ⅰ(57.1%)and type Ⅱ(42.9%). The percentage of Yamada type Ⅰ (36.8%)and type Ⅱ(31.6%) in adenocarcinoma group was lower than that in benign group. Moreover, Yamada type Ⅲ (31.5%) was only found in the adenocarcinoma group. Significant differences were observed between the two groups in Yamada types (=0.046). Most of the benign lesions had clear boundary(18/21, 85.7%). The percentage of clear boundary in adenocarcinoma group (2/19, 10.5%) was significantly lower than that in the benign group ( < 0.001). No significant differences were investigated in color (=0.353) and surface (=0.324) between benign and adenocarcinoma lesions. Pooling age, lesion diameter, Yamada type and clear boundary into Logistic regression analysis, only age (=1.186, 95% 1.025-1.373, =0.022) and clear boundary (=66.218, 95% 3.421-1 281.840, =0.006) were the independent cancer risk factors. Only 2 (10.5%) in the 19 cancer patients had positive biopsy results before EP. As compared with post-EP, 55.3% (21/38) biopsies were under-estimated, including 17 (17/19, 89.5%) adenocarcinomas and 4 (4/10, 40%) grade Ⅱ adenomas.
adenoma and adenocarcinoma were the major histological type of ampullary po-lyps. Age and unclear boundary were the independent risk factors of ampullary adenocarcinoma. Forceps biopsy was not enough for ampullary polyp differentiation.
区分壶腹息肉的内镜及临床特征,基于良性病变与腺癌的差异比较探究壶腹息肉的内镜下癌变危险因素,并评估钳取活检的准确性。
作者回顾性分析了北京大学第三医院消化内科2009年1月至2019年5月接受内镜下乳头切除术(EP)治疗患者的数据。对内窥镜图像和病理报告进行重新评估和分析。比较良性组和癌症组之间的差异。
本研究共纳入42例患者,年龄35至83岁,其中83.3%的患者年龄大于50岁。组织学类型如下:炎性息肉2例(4.8%),神经内分泌肿瘤1例(2.4%),增生性息肉1例(2.4%),Ⅰ级腺瘤5例(11.9%),Ⅱ级腺瘤10例(23.8%),Ⅲ级腺瘤4例(9.5%),腺癌19例(45.2%),腺瘤或腺癌占90.5%。良性组(炎性息肉和腺瘤)的平均年龄为(56.7±9.2)岁,显著低于腺癌组[(66.0±9.8)岁,P = 0.004]。腺癌组肿瘤直径[(2.3±0.8)cm]显著大于良性组[(1.6±0.6)cm,P = 0.002]。良性病变仅表现为山田Ⅰ型(57.1%)和Ⅱ型(42.9%)。腺癌组山田Ⅰ型(36.8%)和Ⅱ型(31.6%)的比例低于良性组。此外,山田Ⅲ型(31.5%)仅在腺癌组中发现。两组在山田分型上存在显著差异(P = 0.046)。大多数良性病变边界清晰(18/21,85.7%)。腺癌组边界清晰的比例(2/19,10.5%)显著低于良性组(P < 0.001)。良性病变与腺癌病变在颜色(P = 0.353)和表面(P = 0.324)方面无显著差异。将年龄、病变直径、山田分型和边界清晰度纳入逻辑回归分析,仅年龄(P = 1.186,95%CI 1.025 - 1.373,P = 0.022)和边界清晰度(P = 66.218,95%CI 3.421 - 1281.840,P = 0.006)是独立的癌变危险因素。19例癌症患者中仅2例(10.5%)在EP前活检结果为阳性。与EP后相比,55.3%(21/38)的活检结果低估,其中腺癌17例(17/19,89.5%),Ⅱ级腺瘤4例(4/10,40%)。
腺瘤和腺癌是壶腹息肉的主要组织学类型。年龄和边界不清是壶腹腺癌的独立危险因素。钳取活检不足以鉴别壶腹息肉。